...
首页> 外文期刊>Medicine. >The efficacy and safety of epinephrine for postoperative bleeding in total joint arthroplasty: A PRISMA-compliant meta-analysis
【24h】

The efficacy and safety of epinephrine for postoperative bleeding in total joint arthroplasty: A PRISMA-compliant meta-analysis

机译:肾上腺素对全关节置换术后出血的疗效和安全性:符合PRISMA的荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Total joint arthroplasty (TJA) usually results in postoperative bleeding. Some randomized controlled trials (RCTs) and nonrandomized controlled trials (non-RCTs) have been performed to evaluate the effects of epinephrine on postoperative bleeding after TJA. However, this remained controversial about the efficacy and safety of epinephrine for postoperative bleeding in TJA. The objective of our meta-analysis was to compare the overall effect and safety of epinephrine and placebo for postoperative bleeding in TJA. Methods: PubMed, Embase, and the Cochrane Library were searched to identify potentially relevant articles. RCTs or non-RCTs involving epinephrine and placebo for blood loss in total knee arthroplasty or total hip arthroplasty were included. Our study was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. RevMan v5.3 was used to analyze the relevant data. Results: Four RCTs and 1 non-RCT involving 646 participants met the inclusion criteria. The overall pooled results from meta-analysis demonstrated that compared with control groups, epinephrine groups could significantly reduce the postoperative bleeding volume (mean difference [MD] = ?168.42, 95% confidence interval [CI]: ?272.37 to ?64.47, P = 0.001). There was no significant difference in intraoperative bleeding volume between epinephrine and control groups (MD = ?12.89, 95% CI: ?53.45 to 27.69, P = 0.53). No significant difference was found between 2 groups in terms of postoperative hemoglobin loss (MD = ?0.28, 95% CI: ?0.66 to 0.10, P = 0.15). Compared with the control groups, no statistically significant difference was found in terms of postoperative transfusion rate in epinephrine groups (relative risk [RR] 0.86, 95% CI: 0.64–1.15, P = 0.31). In addition, the results of the meta-analysis also indicated no significant difference in terms of the incidence rate of deep venous thrombosis (DVT) between 2 groups (RR 0.28, 95% CI: 0.05–1.64, P = 0.16). Conclusion: The meta-analysis showed that epinephrine could significantly reduce postoperative bleeding volume in TJA without increasing the incidence of DVT. However, there was no significant reduction in intraoperative bleeding volume, postoperative hemoglobin loss, and transfusion rate after the administration of epinephrine. Limitations: In this study, a higher heterogeneity and a risk of selection bias may be present in postoperative hemoglobin loss. In addition, the sample size of the included studies was too small, so our findings need to be further validated with more high-quality and larger scale RCTs in the future. Systematic review registration number: None.
机译:背景:全关节置换术(TJA)通常会导致术后出血。已经进行了一些随机对照试验(RCT)和非随机对照试验(non-RCT)来评估肾上腺素对TJA术后出血的影响。然而,关于肾上腺素治疗TJA术后出血的有效性和安全性仍存在争议。我们的荟萃分析的目的是比较肾上腺素和安慰剂对TJA术后出血的总体效果和安全性。方法:搜索PubMed,Embase和Cochrane库,以识别可能相关的文章。包括肾上腺素和安慰剂的RCT或非​​RCT在全膝关节置换术或全髋关节置换术中失血。我们的研究是基于系统评价和荟萃分析的首选报告项目进行的。 RevMan v5.3用于分析相关数据。结果:涉及646名参与者的4项RCT和1项非RCT符合纳入标准。荟萃分析的总体汇总结果显示,与对照组相比,肾上腺素组可以显着减少术后出血量(平均差[MD] = 168.42,95%置信区间[CI]:272.37至64.47,P = 0.001)。肾上腺素与对照组之间的术中出血量无显着差异(MD = 1212.89,95%CI:5353.45至27.69,P = 0.53)。两组在术后血红蛋白损失方面无显着差异(MD = 0.28,95%CI:0.66至0.10,P = 0.15)。与对照组相比,肾上腺素组的术后输血率无统计学差异(相对危险度[RR] 0.86,95%CI:0.64–1.15,P = 0.31)。此外,荟萃分析的结果还表明,两组之间深静脉血栓形成(DVT)的发生率无显着差异(RR 0.28,95%CI:0.05-1.64,P = 0.16)。结论:荟萃分析表明,肾上腺素可显着减少TJA术后出血量,而不会增加DVT的发生率。然而,肾上腺素给药后,术中出血量,术后血红蛋白流失和输血率均没有明显降低。局限性:在这项研究中,术后血红蛋白流失可能存在更高的异质性和选择偏倚的风险。此外,所纳入研究的样本量太小,因此将来我们的研究结果需要更多高质量和更大规模的RCT进行进一步验证。系统评价注册编号:无。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号